1. Homocysteine as a predictor of the severity of coronavirus infection: biochemical justification
    N.V. Vokhmianina et al, 2022, Lab. sluzh. CrossRef
  2. Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism.
    Mohammad Rudiansyah et al, 2022, J Med Virol CrossRef
  3. Thyroid Function During and After COVID-19 Infection: A Review
    Sabri Artun Çabuk et al, 2022 CrossRef
  4. Perspective Chapter: Tracking Trails of SARS CoV-2 – Variants to Therapy
    Ankur Kumar et al, 2022 CrossRef
  5. A case of Kytococcus schroeteri prosthetic valve endocarditis in a patient with COVID-19 infection
    Sweta Shah et al, 2022, Indian Journal of Medical Microbiology CrossRef
  6. N-3 polyunsaturated fatty acids may affect the course of COVID-19
    Barbora Lampova et al, 2022, Front. Immunol. CrossRef
  7. Glucocorticoids and COVID-19
    Stefano Bruscoli et al, 2022, Pharmacological Research CrossRef
  8. Mechanistic Basis of Regulation of Host Epigenetic Landscape and Its Association with Immune Function: A COVID19 Perspective
    Bimal Prasad Jit et al, 2022 CrossRef
  9. Study of thymus volume and density in COVID-19 patients: Is there a correlation in terms of pulmonary CT severity score?
    Banu Alicioglu et al, 2022, Egypt J Radiol Nucl Med CrossRef
  10. Characterization of the Ubiquitin and ISG15 Deconjugase Activity of SARS-CoV-1 and SARS-CoV-2 Papain-Like Protease
    Digant Nayak et al, 2023 CrossRef
  11. Physical as Well as Psychological Distress and Coping with Situational Dilemmas Experienced by People Infected with COVID-19: A Mixed Method Study
    Arunee Hengyotmark et al, 2022, IJERPH CrossRef
  12. An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants
    Muhammad Zafar Irshad Khan et al, 2022, Front. Immunol. CrossRef
  13. Galectin-3 as an important prognostic marker for COVID-19 severity
    Nevena Gajovic et al, 2023, Sci Rep CrossRef
  14. Covid‐19 Histamine theory: Why antihistamines should be incorporated as the basic component in Covid‐19 management?
    Harold L. Mashauri, 2023, Health Science Reports CrossRef
  15. Interleukin-22 and interleukin-33 show up-regulated levels in the serum of patients with mild/moderate Coronavirus disease 2019
    Abdulraheem Y. Majeed et al, 2023, Beni-Suef Univ J Basic Appl Sci CrossRef
  16. Investigating the Impact of COVID-19 Vaccines on Liver Function: Insights From a Single-Institute Study
    Rajmohan Rammohan et al, 2023 CrossRef
  17. Effect of Supplemental Antioxidant-Based Therapy on the Oxidative Stress Level in COVID-19 Patients
    Dragica Zendelovska et al, 2023 CrossRef
  18. Factors Influencing the Intention and Uptake of COVID-19 Vaccines on the African Continent: A Scoping Review
    Damian Naidoo et al, 2023, Vaccines CrossRef
  19. Modern methods of diagnosis and treatment of patients with COVID and post-COVID anosmia
    G. V. Lebedeva et al, 2023, Medicinskij sovet CrossRef
  20. Respiratory Failure in COVID-19 Condition
    Olalekan Bukunmi Ogunro et al, 2023 CrossRef
  21. Reproductive system status in men after coronavirus infection and vaccination
    Kh. T.Dzh. Matar et al, 2023, jour CrossRef
  22. Does atrial fibrillation affect prognosis in hospitalised COVID-19 patients? A multicentre historical cohort study in the Netherlands
    Jocelyn R Spruit et al, 2023, BMJ Open CrossRef
  23. Mesenchymal stem cell therapy for COVID-19 infection
    Seyyed Mohammad Matin Alavi-Dana et al, 2023, Inflammopharmacol CrossRef
  24. Temporal trends in laboratory parameters in survivors and non‑survivors of critical COVID‑19 illness and the effect of dexamethasone treatment
    Stelios Kokkoris et al, 2023, Biomed Rep CrossRef
  25. Interleukin-35 as a New Biomarker for SARS-CoV-2 in Iraqi Patients
    Falah Hasan Obayes AL-Khikani et al, 2024 CrossRef
  26. Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination
    Brittany A. Comunale et al, 2024, Vaccines CrossRef
  27. Association between Presepsin and SARS-CoV-2: A Case–Control Study
    Falah Hasan Obayes AL-Khikani et al, 2024 CrossRef
  28. Incidence of Thrombosis in COVID-19 Patients Compared to Non-COVID-19 Sepsis Patients in the Intensive Care Unit
    Sherri Huang et al, 2024, JCM CrossRef
  29. Post-COVID Neurocognitive Disorder and Its Relation with Interleukin: A Hospital-based Cross-sectional Study
    Ajmal Anjum et al, 2024, Indian Journal of Psychological Medicine CrossRef
  30. SARS-CoV-2 Associated Impact on Reproductive Health: A Global Perspective
    Priya Kalsi et al, 2024, Ind J Clin Biochem CrossRef
  31. SARS-CoV-2 Genome Structure, Pathogenesis, Issues, and Challenges in Laboratory Diagnosis
    Gopal Nath et al, 2023, ANAMS CrossRef
  32. A COMPREHENSIVE REVIEW ON THE MULTIFACETED INTERACTIONS BETWEEN HOST IMMUNITY AND VIRAL PATHOGENESIS IN COVID-19
    MAIREMBAM STELIN SINGH et al, 2024, Int J App Pharm CrossRef
  33. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19
    Yasmin Silva-Santos et al, 2024, Front. Pharmacol. CrossRef
  34. Comparative Efficacy of Inhaled and Intravenous Corticosteroids in Managing COVID-19-Related Acute Respiratory Distress Syndrome
    Ahmed A. Abdelkader et al, 2024, Pharmaceutics CrossRef
  35. Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels
    Anne Caufriez et al, 2022, IJMS CrossRef
  36. Impact of genetic variations of gene involved in regulation of metabolism, inflammation and coagulation on pathogenesis of cardiac injuries associated with COVID-19
    HariOm Singh et al, 2024, Pathology - Research and Practice CrossRef
  37. The IFIH1 gene variants rs1990760 and rs2111485 are associated with COVID-19 susceptibility and affect IFIH1 protein levels in Iraqis
    Abdulraheem Y. Majeed et al, 2024, Egypt J Med Hum Genet CrossRef
  38. Dynamics of Biomarkers in COVID-19 Patients Treated with Anakinra
    Ralitsa Yordanova et al, 2024, Biomedicines CrossRef
  39. Preventive effect of flavor/fragrance components on SARS-CoV-2 infections
    Hidenobu Senpuku et al, 2024, Current Research in Microbial Sciences CrossRef